Cargando…

Efficacy and safety of evocalcet in treatment of secondary hyperparathyroidism in chronic kidney disease on hemodialysis patients: A protocol for a systematic review and meta-analysis

BACKGROUND: Secondary hyperparathyroidism (SHPT) have been associated with poor health outcomes in hemodialysis patients. The cinacalcet has popularized in clinic which has efficacy but more adverse events; the novel oral calcimimetic agents evocalcet has appeared in recent years. However, it is cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jing, Li, Xueying, Chen, Yang, Chen, Ming, Mao, Nan, Fan, Junming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668479/ https://www.ncbi.nlm.nih.gov/pubmed/33181644 http://dx.doi.org/10.1097/MD.0000000000022566

Ejemplares similares

Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
por: Yokoyama, Keitaro, et al.
Publicado: (2019)

Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis
por: Shigematsu, Takashi, et al.
Publicado: (2020)

Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism
por: Tokumoto, Masanori, et al.
Publicado: (2022)

Nitrite-induced acute kidney injury with secondary hyperparathyroidism: Case report and literature review
por: Peng, Tao, et al.
Publicado: (2018)

Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
por: Ni, Zhaohui, et al.
Publicado: (2023)

Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients
por: Koiwa, Fumihiko, et al.
Publicado: (2021)

Full thermal ablation versus partial thermal ablation for secondary hyperparathyroidism: A meta-analysis.
por: Gong, Lifeng, et al.
Publicado: (2023)

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
por: Shigematsu, Takashi, et al.
Publicado: (2022)

A Case of Solitary Kidney Atrophy Due to Primary Hyperparathyroidism: A Case Report
por: Lin, Yu-Ting, et al.
Publicado: (2016)

Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis
por: Liu, Shilin, et al.
Publicado: (2022)

Massive hemorrhage arising of inferior thyroid artery by radiofrequency ablation for secondary hyperparathyroidism: Two case reports
por: Liu, Xiaoling, et al.
Publicado: (2022)

A simplified protocol for individualized regional citrate anticoagulation for hemodialysis: A single-center, randomized clinical study
por: Luo, Laimin, et al.
Publicado: (2021)

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2019)

Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism
por: Sakai, Mariko, et al.
Publicado: (2020)

The clinical effectiveness and safety of traditional Chinese medicine uremic clearance granule combined with high-flux hemodialysis in the treatment of uremic pruritus: A protocol for systematic review and meta analysis
por: Bai, Ya-Fei, et al.
Publicado: (2021)

The impact of exercise intervention for patients undergoing hemodialysis on fatigue and quality of life: A protocol for systematic review and meta-analysis
por: Zhang, Fan, et al.
Publicado: (2020)

Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis
por: Chen, Siqi, et al.
Publicado: (2021)

Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
por: Iwasaki, Masako, et al.
Publicado: (2023)

The effectiveness and safety of extracorporeal shock wave lithotripsy for the management of kidney stones: A protocol of systematic review and meta-analysis
por: Cao, Lin, et al.
Publicado: (2020)

Effect of continuous nursing on quality of life of hemodialysis patients: A protocol for systematic review and meta-analysis
por: Yuan, Ling, et al.
Publicado: (2021)

Evaluation of efficacy and safety of esmolol in treating patients with septic shock: A protocol for systematic review and meta-analysis
por: Hou, Bin, et al.
Publicado: (2022)

Barriers and facilitators to exercise in hemodialysis patients: A protocol for systematic review
por: Li, Tianzi, et al.
Publicado: (2020)

Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats
por: Hasegawa, Tomoka, et al.
Publicado: (2023)

The efficacy of probiotic preparations on inflammatory cytokines in patients with chronic kidney disease: A protocol for systematic review and meta-analysis
por: Wang, Peidong, et al.
Publicado: (2021)

Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese medicinal enemas for treatment of chronic renal failure: A protocol for systematic review and meta-analysis
por: Wu, Lihua, et al.
Publicado: (2020)

Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2021)

Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function
por: Hwang, Hyeon Seok, et al.
Publicado: (2016)

Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials
por: Zhao, Mingming, et al.
Publicado: (2021)

Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial
por: Mei, JuXiang, et al.
Publicado: (2021)

Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis
por: Yusof Khan, Abdul Hanif Khan, et al.
Publicado: (2021)

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Effects of tonifying kidney and strengthen bone therapy on non-dialysis patients with chronic kidney disease-mineral and bone disorder: A protocol for the systematic review and meta-analysis of randomized controlled trials
por: Wu, Zijian, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Aerobic, resistance and combined training for adults with chronic kidney disease: A protocol for a systematic review and network meta-analysis
por: Zeng, Rong, et al.
Publicado: (2020)

Factors affecting willingness to receive a kidney transplant among hemodialysis patients in West China: A cross-sectional survey
por: Tan, Qiling, et al.
Publicado: (2017)

Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis
por: Lu, WanJun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i8m8rf59uklq05dpld3s5vesok